Delivery Order SPE2DB20D1100-SPE2DB25FD3G7

Award Date 7/9/25
Potential Completion Date 7/10/25
Potential Value $59K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $18,736.80 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ORENCIA 125 MG/ML SYRINGEML. The award is not associated with a set-aside program. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides comprehensive global pharmaceutical support for military healthcare programs through December...
This is a $7,385.43 firm fixed-price delivery order contract awarded by the Defense Logistics Agency to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ORENCIA 125 MG/ML SYRINGE. The contract has an ultimate completion date of July 14, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, providing a comprehensive global pharmaceutical support vehicle for...
This is a $14,282.52 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ORENCIA 125 MG/ML SYRINGE, a pharmaceutical product, with a period of performance through May 13, 2025. There is no set-aside designation for this contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
This is a $13,493.18 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to provide ORENCIA 250 MG VIALS. The contract has an ultimate completion date of July 9, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ORENCIA 125 MG/ML SYRINGEML, a specialty pharmaceutical product. The order has a firm fixed price of $6,054.93 and a completion date of June 25, 2025. The contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a $58,192.61 delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 4565504008 - ORENCIA 125 MG/ML SYRINGEML, a pharmaceutical product. The delivery order was issued under a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 held by Amerisourcebergen with DLA Troop Support Medical for delivering a range of medical commodities to support military treatment programs and...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The delivery order, valued at $57,543.03, is for the supply of the pharmaceutical product ORENCIA 125 MG/ML SYRINGE. The award does not have a set-aside designation. AmerisourceBergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ORENCIA 125 MG/ML SYRINGEML, a pharmaceutical product, with a ceiling value of $40,477.39. The contract is a Firm Fixed Price arrangement and has an ultimate completion date of May 27, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,570.63 Firm Fixed Price delivery order is for the supply of ORENCIA 125 MG/ML SYRINGE/ML, a pharmaceutical product. The contract has an ultimate completion date of May 19, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $44,943.56 firm fixed-price delivery order is for the medical product "ORENCIA 125 MG/ML SYRINGEML" and has a completion date of September 26, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FD3G7
    Delivery Order

This is a $59,338.37 firm-fixed price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The order is for ORENCIA 125 MG/ML SYRINGEML, a pharmaceutical product. The order has a completion date of July 10, 2025. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs through December 2026. This delivery order is not set aside and represents an open competition award to Amerisourcebergen Drug Corp, a for-profit organization, to provide the specified pharmaceutical product to the DLA.

Generated 10/12/25, 12:59 AM